By applying the cutoff criteria of fold change ≥ 2 or ≤ 0.5 and p < 0.05, 27 DEGs were acquired, including RNF166, MARCHF1, TRIM10, TRIM7, and so on (Figure 1A), and their expression in cancer and normal samples is shown in Figure 1B. This evidence concerns the gene MARCHF1 and cancer.